Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer
针对 ESR1 激活突变的疫苗可引发抗肿瘤免疫反应并抑制对治疗有抵抗力的 ER+ 乳腺癌中的雌激素信号传导
期刊:Human Vaccines & Immunotherapeutics
影响因子:
doi:10.1080/21645515.2024.2309693
Gabrielle P Dailey, Christopher A Rabiola, Gangjun Lei, Junping Wei, Xiao-Yi Yang, Tao Wang, Cong-Xiao Liu, Melissa Gajda, Amy C Hobeika, Amanda Summers, Robert D Marek, Michael A Morse, Herbert K Lyerly, Erika J Crosby, Zachary C Hartman
